Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Angola
Angola: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 62.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Angola, 2013–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
In 2024, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Angola stood at 62.0%.
Compared with earlier readings it is down 3.1% on the previous year and up 44.2% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Angola peaked at 68.0% in 2018 and was at its lowest, 9.0%, in 2013.
That places Angola 131st out of 146 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 12 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Angola, year by year
| Year | % | Change |
|---|---|---|
| 2013 | 9.0% | — |
| 2014 | 43.0% | +377.8% |
| 2015 | 57.0% | +32.6% |
| 2016 | 58.0% | +1.8% |
| 2017 | 60.0% | +3.4% |
| 2018 | 68.0% | +13.3% |
| 2019 | 64.0% | -5.9% |
| 2020 | 65.0% | +1.6% |
| 2021 | 48.0% | -26.2% |
| 2022 | 39.0% | -18.8% |
| 2023 | 64.0% | +64.1% |
| 2024 | 62.0% | -3.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 51.3% | 9.0% | 68.0% | 7 |
| 2020s | 55.6% | 39.0% | 65.0% | 5 |
Countries ranked near Angola
- 129 Democratic Republic of Congo 63.0% compare
- 129 Laos 63.0% compare
- 131 Marshall Islands 62.0% compare
- 133 New Zealand 60.0% compare
- 134 Bolivia 59.0% compare
- 134 Philippines 59.0% compare
More health data for Angola
- Un projection of annual infant deaths, annual growth rate -1.27 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.05 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 740.2 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31,754 deaths (2100)
- Population ages 0-14, female, annual growth rate 2.43 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.2192 units per person (2025)
- Population ages 0-14, male, annual growth rate 2.49 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.2218 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Angola?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Angola was 62.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Angola?
- The highest recorded value was 68.0% in 2018.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Angola?
- The lowest recorded value was 9.0% in 2013.
- How does Angola rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Angola ranks 131st out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Angola?
- Over the last ten years it is up 44.2%. The long-run trend across the full record is rising.
- Where does this Angola data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 12 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.